Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timo Minssen

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Science (New York, N.Y.)|February 2, 2019
Shadow health records meet new data privacy lawsW Nicholson Price, Margot E Kaminski, Timo Minssen, et al.
Journal of Community Genetics|January 25, 2026
The impacts of pricing and reimbursement policies on access to cell and gene therapies across EuropeYi Han, Mattia Andreoletti, Timo Minssen, et al.
Journal of Law and the Biosciences|May 5, 2025
Patient-centric federated learning: automating meaningful consent to health data sharing with smart contractsKristin M Kostick-Quenet, Marcelo Corrales Compagnucci, Mateo Aboy, et al.
Nature Biotechnology|March 11, 2020
One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections?Mateo Aboy, Cristina Crespo, Kathleen Liddell, et al.
NPJ Digital Medicine|January 15, 2025
A policy framework for leveraging generative AI to address enduring challenges in clinical trialsJohnathon Edward Liddicoat, Gabriela Lenarczyk, Mateo Aboy, et al.
NPJ Digital Medicine|August 30, 2025
Enabling secure and self determined health data sharing and consent managementCindy Welzel, Max Ostermann, Hannah Louise Smith, et al.
Journal of Law and the Biosciences|May 1, 2018
Cutting edges and weaving threads in the gene editing (Я)evolution: reconciling scientific progress with legal, ethical, and social concernsAna Nordberg, Timo Minssen, Sune Holm, et al.
Expert Review of Medical Devices|July 7, 2025
Legal and regulatory challenges in multi-country data-driven projects developing and validating medical AI systems in the EUEmilia Niemiec, Timo Minssen, Patrick A Boland, et al.
Nature Biotechnology|March 18, 2026
Innovation and policy challenges of AI-drug hybridsAndreas Panagopoulos, Katerina Sideri, I Glenn Cohen, et al.
Science Translational Medicine|June 26, 2024
New government drug repurposing programs: Opportunities and uncertaintiesJohnathon Liddicoat, Ashleigh Hamidzadeh, Kathleen Liddell, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Science (New York, N.Y.)|February 2, 2019
Shadow health records meet new data privacy lawsW Nicholson Price, Margot E Kaminski, Timo Minssen, et al.
Journal of Community Genetics|January 25, 2026
The impacts of pricing and reimbursement policies on access to cell and gene therapies across EuropeYi Han, Mattia Andreoletti, Timo Minssen, et al.
Journal of Law and the Biosciences|May 5, 2025
Patient-centric federated learning: automating meaningful consent to health data sharing with smart contractsKristin M Kostick-Quenet, Marcelo Corrales Compagnucci, Mateo Aboy, et al.
Nature Biotechnology|March 11, 2020
One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections?Mateo Aboy, Cristina Crespo, Kathleen Liddell, et al.
NPJ Digital Medicine|January 15, 2025
A policy framework for leveraging generative AI to address enduring challenges in clinical trialsJohnathon Edward Liddicoat, Gabriela Lenarczyk, Mateo Aboy, et al.
NPJ Digital Medicine|August 30, 2025
Enabling secure and self determined health data sharing and consent managementCindy Welzel, Max Ostermann, Hannah Louise Smith, et al.
Journal of Law and the Biosciences|May 1, 2018
Cutting edges and weaving threads in the gene editing (Я)evolution: reconciling scientific progress with legal, ethical, and social concernsAna Nordberg, Timo Minssen, Sune Holm, et al.
Expert Review of Medical Devices|July 7, 2025
Legal and regulatory challenges in multi-country data-driven projects developing and validating medical AI systems in the EUEmilia Niemiec, Timo Minssen, Patrick A Boland, et al.
Nature Biotechnology|March 18, 2026
Innovation and policy challenges of AI-drug hybridsAndreas Panagopoulos, Katerina Sideri, I Glenn Cohen, et al.
Science Translational Medicine|June 26, 2024
New government drug repurposing programs: Opportunities and uncertaintiesJohnathon Liddicoat, Ashleigh Hamidzadeh, Kathleen Liddell, et al.
Pageof 7